FNYS
GALTW

First New York Securities’s Galectin Therapeutics Inc. - Warrants GALTW Stock Holding History

First New York Securities’s Portfolio GALTW Stock Details GALTW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-46,100
Closed -$470K – 423
2014
Q1 		$470K Buy
46,100
+26,200
+132% +$267K 0.23% 101
2013
Q4 		$96K Buy
19,900
+11,400
+134% +$55K 0.06% 111
2013
Q3 		$46K Sell
8,500
-65,755
-89% -$356K 0.02% 199
2013
Q2 		$94K Buy
+74,255
New +$94K 0.04% 178